OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Click here to read the articles and download the PDF
How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.
While new forms of pharmacy continue to surface beyond brick-and-mortar retail, a look at what is driving this shift in perspective—and "pharmacies of the future"—is warranted.
Methods that pharma companies can use to make the hub more personalized and experiential.
December 11, 2023
Conference keynote offers an industry outlook, including new commercialization challenges.
Phase III INTerpath-002 trial will evaluate the novel individualized neoantigen therapy V940 (mRNA-4157) with Keytruda (pembrolizumab) as an adjuvant treatment for patients with non-small cell lung cancer.
To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.
Adults and children aged 1 year and older are eligible for the IV formulation of
Cresemba for invasive aspergillosis and invasive mucormycotic, whereas the prescribed capsule is only indicated for adults and children 6 years of age and older.
December 08, 2023
The rise in demand represents the third consecutive month of year-on-year growth.
FDA approves bluebird bio’s Lyfgenia and Vertex Pharmaceuticals' and CRISPR Therapeutics’ Casgevy for the treatment of sickle cell disease, which affects approximately 100,000 people in the United States.
Study analyzes and predicts how conditions in research and development can be predicted via computer simulation.
PrEPVacc tested two different combinations of vaccines to determine whether either can prevent HIV infection in populations at risk of acquiring the virus.
December 07, 2023
December's installment reinforces the publication's commitment to covering the latest updates on patient support.
Introducing a new style and feel to Pharma Commerce.